Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 5,051–5,075 of 27,380 studies, newest first · page 203 of 1096.

March 2025 25

  1. 2025-03-03

    Alzheimer’s disease diagnosis among dementia patients via blood biomarker measurement based on the AT(N) system

    ✓ Peer-reviewed Cognitive tests and assessment Chinese Medical Journal

    Key finding: A total of 156 patients were clinically diagnosed with dementia based on the 2011 NIA-AA criteria, regardless of specific disease etiology, and all exhibited significant brain atrophy on anatomical magnetic resonance imaging (MRI), indicating neuronal injury (N+). +4 more findings

  2. 2025-03-03

    Multimodal magnetic resonance imaging analysis of early mild cognitive impairment

    ✓ Peer-reviewed Mild cognitive impairment Journal of Alzheimer s Disease

    Key finding: Significant differences were found between EMCI and AD group in fALFF (right insula) and ReHo (bilateral caudate regions). +3 more findings

  3. 2025-03-03

    Machine Learning Analysis of Engagement Behaviors in Older Adults With Dementia Playing Mobile Games: Exploratory Study

    ✓ Peer-reviewed Digital health tools JMIR Serious Games

    Key finding: Significant differences in 64% of engagement-related behaviors were found between groups, notably in torso movements, voice modulation, facial expressions, and concentration. +4 more findings

  4. 2025-03-03

    Cerebrospinal Fluid Beta-Amyloid Concentration and Clinical and Radiographic Manifestations of Cerebral Amyloid Angiopathy

    ✓ Peer-reviewed Tau biomarkers Journal of the American Heart Association

    Key finding: Cerebral amyloid angiopathy (CAA) is driven by vascular Aβ (amyloid-beta) deposition, which can be detected as reduced Aβ species in cerebrospinal fluid (CSF). +3 more findings

  5. 2025-03-03

    Sex Differences in Apolipoprotein E and Alzheimer Disease Pathology Across Ancestries

    ✓ Peer-reviewed Tau biomarkers JAMA network open

    Key finding: Age, sex, and apolipoprotein E (APOE) are the strongest risk factors for late-onset Alzheimer disease (AD). +3 more findings

  6. 2025-03-03

    Sex Differences in Longitudinal Tau-PET in Preclinical Alzheimer Disease: A Meta-Analysis

    ✓ Peer-reviewed Brain scans and imaging JAMA neurology

    Key finding: Mounting evidence in adults without AD indicates that females exhibit higher tau deposition than age-matched males, particularly in the setting of elevated β-amyloid (Aβ), but the evidence for sex differences in tau accumulation rates is inconclusive. +4 more findings

  7. 2025-03-03

    Cardiovascular Health and Biomarkers of Neurodegenerative Disease in Older Adults

    ✓ Peer-reviewed Biomarkers JAMA network open

    Key finding: These findings suggest that promoting CVH in older adults may help alleviate the burden of neurodegenerative diseases, particularly among Black adults, who are known to experience a higher prevalence of cardiovascular disease. +4 more findings

  8. 2025-03-03

    Physical Activity, Alzheimer Plasma Biomarkers, and Cognition

    ✓ Peer-reviewed Biomarkers JAMA network open

    Key finding: These findings suggest that PA may help delay cognitive decline by modulating neurodegeneration and AD-specific tau pathologies. +3 more findings

  9. 2025-03-03

    Multicomponent Intervention for Distressed Informal Caregivers of People With Dementia: A Randomized Clinical Trial

    ✓ Peer-reviewed Caregiving JAMA Network Open

    Key finding: The MBI component significantly improved multiple caregiver outcomes, with reduced depressive symptoms (β = -2.13 [95% CI, -2.85 to -1.38]; P Conclusions and relevance In this clinical trial of informal caregivers of people with dementia, synergistic interaction effects were noted for MBI, which enhanced the benefits of SC and BPM on depression. +1 more finding

  10. 2025-03-02

    Harnessing the Evolution of Proteostasis Networks to Reverse Cognitive Dysfunction

    ⚠ Preprint — not yet peer-reviewed Down syndrome and Alzheimer's bioRxiv

    Key finding: Here, we investigated how persistent ISR activation impacts cognitive performance, primarily focusing on a PPP1R15B R658C genetic variant associated with intellectual disability. +4 more findings

    Scored 19 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  11. 2025-03 month only

    Tau degradation in Alzheimer's disease: Mechanisms and therapeutic opportunities

    ✓ Peer-reviewed Disease mechanisms Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: We emphasize the need for a continuous exploration of tau degradation mechanisms and provide a future perspective for developing tau-targeted degraders, encouraging researchers to work on new treatment options for AD patients. +4 more findings

  12. 2025-03 month only

    Associations among sleep quality, sleep duration, and Alzheimer's disease biomarkers: A systematic review and meta-analysis

    ✓ Peer-reviewed Risk factors Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: In total, 30 studies were included comprising 14,997 subjects. +4 more findings

  13. 2025-03-01

    Cerebral Amyloid Angiopathy: Clinical Presentation, Sequelae and Neuroimaging Features-An Update

    ✓ Peer-reviewed Treatments Biomedicines

    Key finding: Recent findings indicate that treatment should be continued in cases of mild ARIA, with ongoing MRI and clinical monitoring.

  14. 2025-03-01

    Palliative Care in the Community and the Relevance of Percutaneous Endoscopic Gastrostomy Placement to Quality of Life and Survival

    ✓ Peer-reviewed End-of-life care Journal of dementia and Alzheimer's disease

    Key finding: The statistical analysis revealed that the survival time was significantly longer in females compared to males (p = 0.003). +4 more findings

  15. 2025-03-01

    Alone in the Mind: Review of Research Examining the Link Between Loneliness and Dementia

    ✓ Peer-reviewed Prevention trials Medicine Advances

    Key finding: This narrative review focused on research investigating the impact of loneliness on the prevalence of dementia and its relationship with other risk factors. +1 more finding

  16. 2025-03-01
  17. 2025-03-01

    Feasibility and acceptability of a remote computerized cognitive training employing telehealth in older adults with subjective cognitive complaints

    ✓ Peer-reviewed Prevention trials Digital Health

    Key finding: A significant improvement in mental flexibility and planning abilities was observed in both groups (as measured by the Zoo planning test), but no other neuropsychological tests showed improvement. +4 more findings

  18. 2025-03-01

    Astrocyte glypican 5 regulates synapse maturation and stabilization

    ✓ Peer-reviewed Inflammation and the immune system Cell Reports

    Key finding: We show that astrocytes, through production of glypican 5 (GPC5), are required for maturation and refinement of synapses in the mouse cortex during the critical period. +4 more findings

  19. 2025-03-01

    Structural insights and milestones in TDP-43 research: A comprehensive review of its pathological and therapeutic advances

    ✓ Peer-reviewed Brain tissue and pathology International Journal of Biological Macromolecules

    Key finding: This review provides a comprehensive retrospective and prospective analysis of TDP-43 research, highlighting structural insights, significant milestones, and the evolving understanding of its physiological and pathological functions.

  20. 2025-03-01

    Developing and validating a prediction tool for cerebral amyloid angiopathy neuropathological severity

    ✓ Peer-reviewed Brain tissue and pathology Alzheimer s & Dementia

    Key finding: The FCAAS-4 achieved a mean area under the receiver operating characteristic curve (AUC-ROC) of 0.74 (95% confidence interval: 0.71-0.77) and a Harrell generalized c-index of 0.72 (0.70-0.75). +4 more findings

  21. 2025-03-01

    Plasma biomarkers distinguish Boston Criteria 2.0 cerebral amyloid angiopathy from healthy controls

    ✓ Peer-reviewed Brain tissue and pathology Alzheimer s & Dementia

    Key finding: Plasma Aβ 42/40 , p‐tau‐181, and NfL differ in those with CAA and together can discriminate CAA from healthy controls. +3 more findings

  22. 2025-03-01
  23. 2025-03-01

    Statistical Method for Identification of Alzheimer's Disease in Mild Cognitive Impairment with Multimodal Predictive Markers

    ✓ Peer-reviewed Mild cognitive impairment Basic and Clinical Neuroscience Journal

    Key finding: Our findings showed the strong predictive potential of PET, particularly florbetaben (FBB), which achieved an AUC of 0.84. +4 more findings

  24. 2025-03-01

    Heterogeneity of cognitive progression and clinical predictors in Parkinson’s disease–subjective cognitive decline

    ✓ Peer-reviewed Mild cognitive impairment Journal of Neurology

    Key finding: Subjects with PD-SCD do not consistently show cognitive decline, but rather exhibit a heterogeneous progression. +3 more findings

  25. 2025-03-01

    Parkinsonism in Alzheimer's disease without Lewy bodies in association with nigral neuron loss: A data‐driven clinicopathologic study

    ✓ Peer-reviewed Lewy body dementia Alzheimer s & Dementia

    Key finding: Among 635 AD patients without LB, 62 (9.7%) presented parkinsonism, which correlated with reduced nigral neuron density (p < 0.01). +4 more findings

Browse the library by subject, with the full score breakdown →